In the BioHarmony Drug Report Database

"Preview" Icon

Cefiderocol

Fetroja, Fetcroja (cefiderocol) is a small molecule pharmaceutical. Cefiderocol was first approved as Fetroja on 2019-11-14. It is used to treat bacterial infections, pyelonephritis, and urinary tract infections in the USA. It has been approved in Europe to treat gram-negative bacterial infections. Fetroja’s patents are valid until 2035-09-03 (FDA).

 

Trade Name

 

Fetcroja
 

Common Name

 

cefiderocol
 

ChEMBL ID

 

CHEMBL3989974
 

Indication

 

bacterial infections, gram-negative bacterial infections, pyelonephritis, urinary tract infections
 

Drug Class

 

Cephalosporins

Image (chem structure or protein)

Cefiderocol structure rendering